HANAROSTENT Esophagus TTS(CCC): payments to doctors
Payments that named HANAROSTENT Esophagus TTS(CCC) as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.7M
- Providers
- 308
- Transactions
- 715
- Average per transaction
- $2,363
The per-transaction average — $2,363 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 308 providers the average total is $5,485, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Olympus Corporation Of The Americas | $1,653,571 | 97.9% |
| Olympus America Inc. | $35,738 | 2.1% |